|Podcasts|November 7, 2019
Episode 43: Pharma Reputation
Author(s)Christen Harm, Elaine Quilici
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
Advertisement
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
2
Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction
3
Nimbus Therapeutics and Eli Lilly Enter $1.3 Billion License Agreement and Research Collaboration for Oral Obesity Treatments
4
Parental Control: Why Pharma’s Strongest Asset May Be Its Parent Brand
5